Terms: = Bone cancer AND MSI2, ENSG00000153944, 124540
5 results:
1. MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia.
Li F; Han Y; Chen R; Jiang Y; Chen C; Wang X; Zhou J; Xu Q; Jiang S; Zhang S; Yu K; Zhang S
J Transl Med; 2023 May; 21(1):309. PubMed ID: 37149661
[TBL] [Abstract] [Full Text] [Related]
2. Competitive evolved sub-clonal BCR::ABL1 and novel msi2::PC fusion genes in myelodysplastic syndrome with isolated del(5q).
Zhang Y; Liu Y; Wang T; Wang H; Chen X; Cao P; Ma X; Liu M; Xu P; Bi H; Pan J; Jiang Y; Li X; Wang W; Liu H
Hematol Oncol; 2023 Feb; 41(1):178-181. PubMed ID: 36301018
[TBL] [Abstract] [Full Text] [Related]
3.
Liu M; Du M; Yu J; Qian Z; Gao Y; Pan W; Zhao X; Wang M; Li H; Zheng J; Huang Q; Wang LM; Xiao H
Oncoimmunology; 2022; 11(1):2016158. PubMed ID: 35003895
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA DANCR regulates osteosarcoma migration and invasion by targeting miR-149/msi2 axis.
Zhang W; Li JZ; Tai QY; Tang JJ; Huang YH; Gao SB
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6551-6560. PubMed ID: 32633342
[TBL] [Abstract] [Full Text] [Related]
5. Suppression of Musashi‑2 by the small compound largazole exerts inhibitory effects on malignant cells.
Wang M; Sun XY; Zhou YC; Zhang KJ; Lu YZ; Liu J; Huang YC; Wang GZ; Jiang S; Zhou GB
Int J Oncol; 2020 May; 56(5):1274-1283. PubMed ID: 32319553
[TBL] [Abstract] [Full Text] [Related]
